Preventability and manageability of adverse drug reactions in COVID-19 with mucormycosis: An observational study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sajal,Dhingra

第一单位： Veer Madho Singh Bhandari, Uttarakhand Technical University, Dehradun, Uttarakhand, India.;Department of Pharmacology, Regional Adverse Drug Reaction Monitoring Center, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

作者： Sajal,Dhingra ^[1] ; Raj,Hanjong ^[1] ; Khushboo,Bisht ^[2] ; Puneet,Dhamija ^[2] ; Minakshi,Dhar ^[3]

作者单位： Veer Madho Singh Bhandari, Uttarakhand Technical University, Dehradun, Uttarakhand, India.;Department of Pharmacology, Regional Adverse Drug Reaction Monitoring Center, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. ^[1] Department of Pharmacology, Regional Adverse Drug Reaction Monitoring Center, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. ^[2] Department of Internal Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. ^[3]

关键词 Adverse drug reactions COVID-19 mucormycosis preventability

DOI 10.4103/jfmpc.jfmpc_1691_23

PMID 39464916

发布时间 2024-10-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of family medicine and primary care

2024年13卷9期

3672-3678页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Preventability and manageability of adverse drug reactions in COVID-19 with mucormycosis: An observational study.

Journal of family medicine and primary care

相似文献

Journal of family medicine and primary care

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Preventability and manageability of adverse drug reactions in COVID-19 with mucormycosis: An observational study.

Journal of family medicine and primary care

相似文献

Journal of family medicine and primary care

相关期刊

检索历史清除